About
Medical Devices
Areas of Focus
Categories
Surgical DeviceWound HealingMidwest
Clinical Trials (27)
View allTotal Trials
27
As Lead Sponsor
19
As Collaborator
8
Total Enrollment
9,997
By Phase
PHASE4: 8NA: 7PHASE3: 3
By Status
COMPLETED: 16TERMINATED: 4RECRUITING: 3WITHDRAWN: 2UNKNOWN: 2
Clinical Trials Pipeline27 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07141004Lead Sponsor
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
PHASE4Recruiting
100 participants
Started: Aug 12, 2025 · Completed: Sep 11, 2027
NCT07030517Lead Sponsor
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
PHASE4Recruiting
75 participants
Started: May 22, 2025 · Completed: Jun 20, 2027
NCT04288778Lead Sponsor
A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes
PHASE4Completed
276 participants
Started: Nov 25, 2020 · Completed: Jul 26, 2022
NCT03190330Lead Sponsor
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
PHASE4Completed
75 participants
Started: Jun 26, 2019 · Completed: May 3, 2023
NCT03768960Lead Sponsor
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent
PHASE4Completed
150 participants
Started: Jun 10, 2019 · Completed: Jul 16, 2022
Locations (1)
Headquarters
Warsaw, IN, United States
Map
Loading map...